In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy

Chimeric antigen receptor-T (CAR-T) cell-based therapy has become a successful option for treatment of numerous hematological malignancies, but also raises hope in a range of non-malignant diseases. However, in a traditional approach, generation of CAR-T cells is associated with the separation of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Śledź, Marta, Wojciechowska, Alicja, Zagożdżon, Radosław, Kaleta, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329070/
https://www.ncbi.nlm.nih.gov/pubmed/37419996
http://dx.doi.org/10.1007/s00005-023-00683-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329070/
https://www.ncbi.nlm.nih.gov/pubmed/37419996
http://dx.doi.org/10.1007/s00005-023-00683-y

Ejemplares similares